Systemic Lupus Erythematosus, An Issue of Rheumatic Disease Clinics, 1st Edition
Author :
By Ellen M. Ginzler, MD, MPH
This issue brings the rheumatologist on the current thinking on treatment of Systemic Lupus Erythematosus, with an eye to the future. Topics covered include B cell biology and related therapies; glutamate receptor biology and its clinical significan
...view more
This issue brings the rheumatologist on the current thinking on treatment of Systemic Lupus Erythematosus, with an eye to the future. Topics covered include B cell biology and related therapies; glutamate receptor biology and its clinical significance in neuropsychiatric SLE; platelet C4d and vascular complications; biomarkers in lupus nephritis; endothelial function and its implications for cardiovascular and renal disease in SLE; changing worldwide epidemiology of SLE and its relationship to environmental, ethnic, and other sociodemographic factors; work loss, disability, quality of life, and compliance in SLE; pediatric lupus; metabolic syndrome and related endocrine abnormalities; the significance of interferon and the consequences of anti-interferon in SLE; and cutaneous lupus and the CLASI instrument.
This issue brings the rheumatologist on the current thinking on treatment of Systemic Lupus Erythematosus, with an eye to the future. Topics covered include B cell biology and related therapies; glutamate receptor biology and its clinical significance in neuropsychiatric SLE; platelet C4d and vascular complications; biomarkers in lupus nephritis; endothelial function and its implications for cardiovascular and renal disease in SLE; changing worldwide epidemiology of SLE and its relationship to environmental, ethnic, and other sociodemographic factors; work loss, disability, quality of life, and compliance in SLE; pediatric lupus; metabolic syndrome and related endocrine abnormalities; the significance of interferon and the consequences of anti-interferon in SLE; and cutaneous lupus and the CLASI instrument.
Author Information
By Ellen M. Ginzler, MD, MPH, Department of Medicine, Rheumatology Division
State University of New York Downstate Medical Center
Brooklyn
NY
https://www.asia.elsevierhealth.com/systemic-lupus-erythematosus-an-issue-of-rheumatic-disease-clinics-9781437718690.html306846Systemic Lupus Erythematosus, An Issue of Rheumatic Disease Clinicshttps://www.asia.elsevierhealth.com/media/catalog/product/https://www.asia.elsevierhealth.com/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.png89.0998.99USDInStock/Medicine/Rheumatology/Clinics/Clinics/Medicine/Rheumatology/Japan Titles5054555505466652550415259835526316014886536505455351451205259833This issue brings the rheumatologist on the current thinking on treatment of Systemic Lupus Erythematosus, with an eye to the future. Topics covered include B cell biology and related therapies; glutamate receptor biology and its clinical significance in neuropsychiatric SLE; platelet C4d and vascular complications; biomarkers in lupus nephritis; endothelial function and its implications for cardiovascular and renal disease in SLE; changing worldwide epidemiology of SLE and its relationship to environmental, ethnic, and other sociodemographic factors; work loss, disability, quality of life, and compliance in SLE; pediatric lupus; metabolic syndrome and related endocrine abnormalities; the significance of interferon and the consequences of anti-interferon in SLE; and cutaneous lupus and the CLASI instrument. This issue brings the rheumatologist on the current thinking on treatment of Systemic Lupus Erythematosus, with an eye to the future. Topics covered include B cell biology and related therapies; glutamate receptor biology and its clinical significance in neuropsychiatric SLE; platelet C4d and vascular complications; biomarkers in lupus nephritis; endothelial function and its implications for cardiovascular and renal disease in SLE; changing worldwide epidemiology of SLE and its relationship to environmental, ethnic, and other sociodemographic factors; work loss, disability, quality of life, and compliance in SLE; pediatric lupus; metabolic syndrome and related endocrine abnormalities; the significance of interferon and the consequences of anti-interferon in SLE; and cutaneous lupus and the CLASI instrument.00add-to-cart97814377186902011 and earlierProfessionalBy Ellen M. Ginzler, MD, MPH20101Book152w x 229h (6.00" x 9.00")Saunders0Mar 31, 2010IN STOCKBy <STRONG>Ellen M. Ginzler</STRONG>, MD, MPH, Department of Medicine, Rheumatology Division
State University of New York Downstate Medical Center
Brooklyn
NYClinicsClinicsThe Clinics: Internal MedicineUnited StatesNoNoNoNoPlease SelectPlease SelectPlease Select